The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
This research is being done to help us learn about how different factors related to treatment affect rheumatoid arthritis (RA). This is not a treatment study. We will follow the patient for one year as he or she receives usual treatment from his or her rheumatologist. Up to 360 adults with RA may join this study.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
19 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Individuals diagnosed with rheumatoid arthritis and receiving treatment for this condition from a rheumatologist
Males and females age 19 or older
Current active, adult-onset rheumatoid arthritis who meet American College of Rheumatology (ACR) criteria for RA and have: (ACR functional class I-III), defined as:
3 or more swollen or tender joints and
Morning stiffness of 45min or longer
OR judged by their rheumatologist to have active disease
No evidence of other inflammatory diseases (e.g., Crohn's, IBS)
Functional class I, II or III
Individuals with significant cardiovascular disease (CHF, stroke, MI)
Unwilling to have medications monitored and/or comply with protocol
Not fluent in English
Planning to move from area within next year or change health insurance (which would preclude ongoing care by a Johns Hopkins rheumatologist)
Enrolled in study evaluating efficacy of new or existing RA medications